Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Cipla
Baxter
Farmers Insurance
Covington
Dow
Chinese Patent Office
Cerilliant
Healthtrust

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084897

« Back to Dashboard

NDA 084897 describes CAM-AP-ES, which is a drug marketed by Chartwell Rx and is included in one NDA. Additional details are available on the CAM-AP-ES profile page.

The generic ingredient in CAM-AP-ES is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for 084897
Tradename:CAM-AP-ES
Applicant:Chartwell Rx
Ingredient:hydralazine hydrochloride; hydrochlorothiazide; reserpine
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;15MG;0.1MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Chubb
US Department of Justice
Harvard Business School
McKinsey
Fish and Richardson
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.